Preferred Name | Pancuronium Bromide | |
Synonyms |
Pancuronium Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, Dibromide PANCURONIUM BROMIDE 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide Pancuronium Bromide Pavulon |
|
Definitions |
The bromide salt form of pancuronium, a synthetic, long-acting ammonio steroid muscle relaxant with curarimimetic, some antimuscarinic and sympathomimetic effects. Pancuronium bromide competitively binds to the nicotinic receptor at the neuromuscular junction, thereby preventing acetylcholine binding and resulting in skeletal muscle relaxation and paralysis. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47651 |
|
CAS_Registry |
15500-66-0 |
|
CHEBI_ID |
CHEBI:7908 |
|
Chemical_Formula |
C35H60N2O4.2Br |
|
code |
C47651 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C156952 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C159412 |
|
Contributing_Source |
CPTAC FDA |
|
DEFINITION |
The bromide salt form of pancuronium, a synthetic, long-acting ammonio steroid muscle relaxant with curarimimetic, some antimuscarinic and sympathomimetic effects. Pancuronium bromide competitively binds to the nicotinic receptor at the neuromuscular junction, thereby preventing acetylcholine binding and resulting in skeletal muscle relaxation and paralysis. |
|
FDA_UNII_Code |
U9LY9Y75X2 |
|
FULL_SYN |
Pancuronium Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, Dibromide PANCURONIUM BROMIDE 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide Pancuronium Bromide Pavulon |
|
Has_Free_Acid_Or_Base_Form | ||
label |
Pancuronium Bromide |
|
Legacy Concept Name |
Pancuronium_Bromide |
|
NSC Number |
293162 |
|
Preferred_Name |
Pancuronium Bromide |
|
prefixIRI |
Thesaurus:C47651 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0030311 |
|
subClassOf |